Horizon can restructure: 4 things to know

New Jersey’s governor signed legislation Dec. 23 that allows Horizon Blue Cross Blue Shield of New Jersey to reorganize its business structure, according to the Asbury Park Press.

Advertisement

Four things to know: 

1. With Gov. Phil Murphy’s signature, Horizon can convert from a nonprofit health services corporation to a nonprofit mutual holding company. 

2. The change will allow Horizon to acquire other providers and pharmacy benefit managers, according to the report. The legislation says that Horizon cannot become a for-profit company, but it can create for-profit subsidiaries.

3. Opponents of the legislation have been wary about how the change would affect members, arguing it would allow Horizon to become a for-profit enterprise that focuses more on shareholders than members, according to the Asbury Park Press.

4. Under the restructure, Horizon agreed to pay New Jersey $1.25 billion over 18 years, including $600 million in 2021, according to the report. 

Read more here.

More articles on payers:
California health plan files for bankruptcy
Intermountain, UnitedHealthcare launch ACO
Haven exec leaves for BCBS of Massachusetts

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Strategy

Advertisement

Comments are closed.